BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 8597559)

  • 1. The role of HLA class II antigens in the induction of cytotoxic T lymphocytes.
    Demesová V; Buc M; Ferencík S; Sasazuki T; Shawkatová I; Porubská S
    Eur J Immunogenet; 1995 Dec; 22(6):425-34. PubMed ID: 8597559
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of HLA-DQ antigens in the induction of cytotoxic T lymphocytes.
    Porubská S; Buc M; Bencová M; Sausová E
    Folia Biol (Praha); 1993; 39(5):256-61. PubMed ID: 8206171
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influence of HLA-DP mismatches on primary MLR responses in unrelated HLA-A, B, DR, DQ, Dw identical pairs in allogeneic bone marrow transplantation.
    Cesbron A; Moreau P; Milpied N; Muller JY; Harousseau JL; Bignon JD
    Bone Marrow Transplant; 1990 Nov; 6(5):337-40. PubMed ID: 1981326
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Monoclonal antibodies to HLA-DP, DQ, and DR determinants: functional effects on the activation and proliferation of normal and EBV-transformed B cells.
    Howard DR; Eaves AC; Takei F
    Exp Hematol; 1986 Oct; 14(9):887-95. PubMed ID: 2428652
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunochemical and functional analysis of HLA class II antigens induced by recombinant immune interferon on normal epidermal melanocytes.
    Tsujisaki M; Igarashi M; Sakaguchi K; Eisinger M; Herlyn M; Ferrone S
    J Immunol; 1987 Feb; 138(4):1310-6. PubMed ID: 3100635
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential expression of HLA-DR, DQ, and DP antigens in primary and metastatic melanoma.
    van Vreeswijk H; Ruiter DJ; Bröcker EB; Welvaart K; Ferrone S
    J Invest Dermatol; 1988 May; 90(5):755-60. PubMed ID: 3283252
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Monocytes are differentially activated through HLA-DR, -DQ, and -DP molecules via mitogen-activated protein kinases.
    Matsuoka T; Tabata H; Matsushita S
    J Immunol; 2001 Feb; 166(4):2202-8. PubMed ID: 11160273
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential tissue distribution of HLA-DR, -DP and -DQ antigens.
    Forsum U; Claesson K; Jonsson R; Karlsson-Parra A; Klareskog L; Scheynius A; Tjernlund U
    Adv Exp Med Biol; 1987; 216A():233-9. PubMed ID: 3687525
    [No Abstract]   [Full Text] [Related]  

  • 9. Dw subtypes of serologically defined DR-DQ specificities restrict recognition of cytomegalovirus.
    Linner KM; Monroy C; Bach FH; Gehrz RC
    Hum Immunol; 1986 Oct; 17(2):79-86. PubMed ID: 2428785
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Detection of antibodies specific for HLA-A,B,C,DR,DQ and DP by the erythrocyte antibody rosette inhibition (EAI) and immune phagocytosis inhibition (IPI) tests.
    Faust A; Neppert J
    J Immunol Methods; 1987 Aug; 102(1):71-5. PubMed ID: 3476673
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gamma interferon induces detectable serological and functional expression of DR and DP but not DQ antigens on cultured amniotic fluid cells.
    Maurer DH; Callaway C; Sorkin S; Pollack MS
    Tissue Antigens; 1988 Apr; 31(4):174-82. PubMed ID: 3136555
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analysis of HLA-class II DQA1, DQB1, DRB1 and DPB1 in Italian multiple sclerosis patients.
    Ciusani E; Allen M; Sandberg-Wollheim M; Eoli M; Salmaggi A; Milanese C; Nespolo A; Gyllensten U
    Eur J Immunogenet; 1995 Apr; 22(2):171-8. PubMed ID: 7605774
    [TBL] [Abstract][Full Text] [Related]  

  • 13. T cells from the peripheral blood of coeliac disease patients recognize gluten antigens when presented by HLA-DR, -DQ, or -DP molecules.
    Gjertsen HA; Sollid LM; Ek J; Thorsby E; Lundin KE
    Scand J Immunol; 1994 Jun; 39(6):567-74. PubMed ID: 8009173
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of HLA-A and -DPB1 matching in corneal transplantation.
    Morita N; Munkhbat B; Gansuvd B; Kanai N; Hagihara M; Shimazaki J; Tsubota K; Tsuji K
    Transplant Proc; 1998 Nov; 30(7):3491-2. PubMed ID: 9838531
    [No Abstract]   [Full Text] [Related]  

  • 15. Comprehensive Analysis of CD4
    Hyun YS; Jo HA; Lee YH; Kim SM; Baek IC; Sohn HJ; Cho HI; Kim TG
    Front Immunol; 2020; 11():602014. PubMed ID: 33658991
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of HLA-A,B,C, beta 2-microglobulin (beta 2m), HLA-DR, -DP, -DQ and of HLA-D-associated invariant chain (Ii) in soft-tissue tumors.
    Mechtersheimer G; Staudter M; Majdic O; Dörken B; Moldenhauer G; Möller P
    Int J Cancer; 1990 Nov; 46(5):813-23. PubMed ID: 2228310
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Monoclonal antibodies that distinguish between class II antigens (HLA-DP, DQ, and DR) in 14 haplotypes.
    Robbins PA; Evans EL; Ding AH; Warner NL; Brodsky FM
    Hum Immunol; 1987 Apr; 18(4):301-13. PubMed ID: 3494718
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predictability of alloreactivity among unrelated individuals: role for HLA-DPB1.
    Awdeh ZL; Alper CA; Fici DA; Ronco P; Yunis EJ
    Tissue Antigens; 1995 Sep; 46(3 ( Pt 1)):180-6. PubMed ID: 8525477
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Response to hepatitis B vaccine: multiple HLA genes are involved.
    Desombere I; Willems A; Leroux-Roels G
    Tissue Antigens; 1998 Jun; 51(6):593-604. PubMed ID: 9694351
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In cutaneous T-cell lymphoma, class II MHC molecules on CD1+ antigen-presenting cells are upregulated in involved compared with uninvolved epidermis.
    Hansen ER; Bang B; Larsen JK; Vejlsgaard GL; Baadsgaard O
    Br J Dermatol; 1994 Dec; 131(6):780-8. PubMed ID: 7531998
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.